Wave Life Sciences (WVE) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Wave Life Sciences (WVE) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.04 of bullish evidence against -0.36 bearish.

Wave Life Sciences last closed at $3.46, -0.29% on the session.

Against the IVW growth benchmark the position is -1.09% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for WVE so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Wave Life Sciences in the 18th percentile on return on equity, where 100 is best.

Wave Life Sciences is classified under Health Care / Pharmaceuticals, with a market capitalisation of $683.76M.

StockMap tracks Wave Life Sciences as the 69th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Wave Life Sciences ranks 111th of 151 in the group, against a group median of -0.08.